Complete list of Ipsen presentations at TOXINS 2026: ...
Ipsen has announced the presentation of new study data on Dysport (abobotulinumtoxinA) in stroke and other neurological ...
Botulinum toxin therapy has emerged as a pivotal treatment in the management of spasticity, a debilitating neuromuscular condition characterised by increased muscle tone and hyperactive reflexes. By ...
Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...
Dry needling has emerged as a minimally invasive intervention utilised in neurorehabilitation to manage spasticity, particularly following stroke. This technique involves the insertion of fine needles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback